RNA Biomarkers as a Response Measure for Survival in Patients with Metastatic Castration-Resistant Prostate Cancer

SIMPLE SUMMARY: Despite the increasing number of treatments for advanced prostate cancer, the evaluation of the added value of each line of treatment on survival outcome is challenging. Therefore, biomarkers to discriminate short-term survivors from long-term survivors shortly after start of treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Boerrigter, Emmy, Benoist, Guillemette E., van Oort, Inge M., Verhaegh, Gerald W., de Haan, Anton F. J., van Hooij, Onno, Groen, Levi, Smit, Frank, Oving, Irma M., de Mol, Pieter, Smilde, Tineke J., Somford, Diederik M., Hamberg, Paul, Dezentjé, Vincent O., Mehra, Niven, van Erp, Nielka P., Schalken, Jack A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699291/
https://www.ncbi.nlm.nih.gov/pubmed/34944897
http://dx.doi.org/10.3390/cancers13246279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699291/
https://www.ncbi.nlm.nih.gov/pubmed/34944897
http://dx.doi.org/10.3390/cancers13246279

Ejemplares similares